ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 151 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $558 | -99.9% | 170 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $782,000 | -59.7% | 54,477 | -59.1% | 0.00% | -60.0% |
| Q2 2020 | $1,942,000 | -92.1% | 133,254 | -95.4% | 0.01% | -93.1% |
| Q1 2020 | $24,590,000 | -34.6% | 2,889,541 | +26.5% | 0.07% | -14.3% |
| Q4 2019 | $37,625,000 | +19.7% | 2,284,473 | +2.6% | 0.08% | +9.1% |
| Q3 2019 | $31,426,000 | +51.9% | 2,225,666 | +116.4% | 0.08% | +54.0% |
| Q2 2019 | $20,683,000 | -42.4% | 1,028,507 | +13.9% | 0.05% | -43.8% |
| Q1 2019 | $35,906,000 | +68.9% | 903,307 | +47.6% | 0.09% | +53.4% |
| Q4 2018 | $21,264,000 | +8.2% | 612,100 | +28.8% | 0.06% | +26.1% |
| Q3 2018 | $19,658,000 | +12.5% | 475,400 | 0.0% | 0.05% | -9.8% |
| Q2 2018 | $17,471,000 | -6.0% | 475,400 | -0.2% | 0.05% | -5.6% |
| Q1 2018 | $18,585,000 | – | 476,541 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
| M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
| Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
| MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
| Baupost Group | 8,123,616 | $26,645 | 0.44% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
| WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
| STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
| Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |